LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

LLY

1,042.27

-1.11%↓

JNJ

246.2

+0.25%↑

ABBV

228.42

-0.4%↓

NVS

166.68

+1.33%↑

MRK

123.89

+0.15%↑

Search

Inspire Medical Systems Inc

Fechado

SetorSaúde

57.69 -0.98

Visão Geral

Variação de preço das ações

24h

Atual

Mín

56.96

Máximo

59.13

Indicadores-chave

By Trading Economics

Rendimento

126M

136M

Vendas

45M

269M

P/E

Médio do Setor

11.92

108.767

Margem de lucro

50.577

Funcionários

1,333

EBITDA

33M

50M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+57.18% upside

Dividendos

By Dow Jones

Próximos Ganhos

4 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-268M

1.7B

Abertura anterior

58.67

Fecho anterior

57.69

Sentimento de Notícias

By Acuity

50%

50%

161 / 351 Ranking em Healthcare

Inspire Medical Systems Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de fev. de 2026, 23:07 UTC

Ganhos

Woolworths 1st Half Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 de fev. de 2026, 23:01 UTC

Ganhos

Fortescue 1st Half Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 de fev. de 2026, 22:59 UTC

Ganhos

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability -- Update

24 de fev. de 2026, 22:42 UTC

Ganhos

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability

24 de fev. de 2026, 22:24 UTC

Aquisições, Fusões, Aquisições de Empresas

Warner Bros. Discovery Board Says Paramount Skydance's New Proposal Could Top Netflix Agreement -- Update

24 de fev. de 2026, 23:46 UTC

Conversa de Mercado

Gold Edges Higher Amid Possible Position Adjustments -- Market Talk

24 de fev. de 2026, 23:36 UTC

Conversa de Mercado

Nikkei May Rise, Tracking Wall Street's Rebound -- Market Talk

24 de fev. de 2026, 23:30 UTC

Conversa de Mercado

Fortescue's Copper Bet Is Long Term, While Iron Ore Remains Near-Term Driver -- Market Talk

24 de fev. de 2026, 23:20 UTC

Conversa de Mercado

Fortescue Dividend Beat Overshadows Profit Miss -- Market Talk

24 de fev. de 2026, 23:20 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

24 de fev. de 2026, 23:16 UTC

Ganhos

Oversea-Chinese Banking Corp.'s CEO: "Looking Ahead, We Remain Cautious Yet Positive">O39.SG

24 de fev. de 2026, 23:13 UTC

Ganhos

Oversea-Chinese Banking Corp. FY25 Non-Interest Income S$5.46B Vs. S$4.72B >O39.SG

24 de fev. de 2026, 23:12 UTC

Ganhos

Oversea-Chinese Banking Corp.: FY25 Net Interest Income S$9.15B Vs. S$9.76B>O39.SG

24 de fev. de 2026, 23:10 UTC

Ganhos

Oversea-Chinese Banking Corp. FY25 NPL Ratio 0.9%, Unchanged on Year>O39.SG

24 de fev. de 2026, 23:10 UTC

Ganhos

Oversea-Chinese Banking Corp. FY25 Net Interest Margin 1.91%, Down 29bps on Year>O39.SG

24 de fev. de 2026, 23:08 UTC

Ganhos

Oversea-Chinese Banking Corp. FY25 Net S$7.42B Vs. Net S$7.59B >O39.SG

24 de fev. de 2026, 23:07 UTC

Ganhos

Oversea-Chinese Banking Corp. FY25 Total Income S$14.61B Vs. S$14.47B>O39.SG

24 de fev. de 2026, 22:52 UTC

Ganhos

Woolworths 1H Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 de fev. de 2026, 22:46 UTC

Ganhos

Fortescue 1H Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 de fev. de 2026, 22:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Warner Receives New Bid From Paramount -- 3rd Update

24 de fev. de 2026, 22:29 UTC

Ganhos

Woolworths: FY Ebit Growth for Australian Food Expected at Upper End of Mid-to-High Single Digit Range Provided in August

24 de fev. de 2026, 22:28 UTC

Ganhos

Woolworths: Australian Food Current Growth Rates Reflect Some Benefit from Cycling of Industrial Action Impacts

24 de fev. de 2026, 22:27 UTC

Ganhos

Woolworths: Australian Food Sales +7.2% Excluding Tobacco in 2H First Seven Weeks

24 de fev. de 2026, 22:27 UTC

Ganhos

Woolworths: Australian Food Sales +5.8% in 2H First Seven Weeks

24 de fev. de 2026, 22:25 UTC

Ganhos

Woolworths: Customers Continue to be Value-Focused, Shopping Multiple Retailers in Highly Competitive Environment

24 de fev. de 2026, 22:24 UTC

Ganhos

Woolworths: Trading in 3Q to Date Has Been Strong in Australian Food

24 de fev. de 2026, 22:23 UTC

Ganhos

Woolworths 1H Group Sales A$37.1 Bln, Up 3.4%

24 de fev. de 2026, 22:22 UTC

Ganhos

Woolworths Interim Dividend 45 Australian Cents/Share

24 de fev. de 2026, 22:22 UTC

Ganhos

Woolworths 1H Profit Before Significant Items A$859 Mln, Up 16.4%

24 de fev. de 2026, 22:21 UTC

Ganhos

Woolworths 1H Statutory Net Profit A$374 Mln, Down 49.4%

Comparação entre Pares

Variação de preço

Inspire Medical Systems Inc Previsão

Preço-alvo

By TipRanks

57.18% parte superior

Previsão para 12 meses

Média 91.62 USD  57.18%

Máximo 175 USD

Mínimo 60 USD

Com base em 18 analistas de Wall Street que oferecem metas de preço de 12 meses para Inspire Medical Systems Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

18 ratings

6

Comprar

12

Manter

0

Vender

Sentimento

By Acuity

161 / 351 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
help-icon Live chat